Showing results (1711-1720 of 1,742) with videos related to

Sort By:
Pageof 175
Blood Cancer Journal|November 6, 2025
CHIP amplifies the risk of lymphoid malignancies in individuals with monoclonal B-cell lymphocytosis (MBL)Nicholas J Boddicker, Tait D Shanafelt, Sameer A Parikh, et al.
British Journal of Haematology|July 15, 2025
The role of imaging studies in predicting time to first treatment and overall survival in high-count monoclonal B-cell lymphocytosisSamuel Kosydar, William J Archibald, Paul J Hampel, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 25, 2010
Genetic susceptibility variants for chronic lymphocytic leukemiaSusan L Slager, Lynn R Goldin, Sara S Strom, et al.
The New England Journal of Medicine|August 1, 2019
Ibrutinib-Rituximab or Chemoimmunotherapy for Chronic Lymphocytic LeukemiaTait D Shanafelt, Xin V Wang, Neil E Kay, et al.
Diabetes|January 14, 2025
Cisplatin Exposure Dysregulates Insulin Secretion in Male and Female MiceLahari Basu, Lili Grieco-St-Pierre, Ma Enrica Angela Ching, et al.
Journal of Clinical and Translational Science|February 27, 2023
Barriers to and solutions for representative inclusion across the lifespan and in life course research: The need for structural competency highlighted by the COVID-19 pandemicMadison N LeCroy, Lindsey N Potter, Karen Bandeen-Roche, et al.
Journal of Thrombosis and Haemostasis : JTH|September 29, 2024
Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolismAmber B Koehler, Kari G Rabe, Daniel J Crusan, et al.
Frontiers in Neurology|January 2, 2023
Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapiesEli Hatchwell, Edward B Smith, Shapour Jalilzadeh, et al.
Leukemia|February 20, 2014
The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patientsP Guglielmelli, T L Lasho, G Rotunno, et al.
Blood|April 15, 2022
Long-term outcomes for ibrutinib-rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trialTait D Shanafelt, Xin Victoria Wang, Curtis A Hanson, et al.
Pageof 175